Miraki Innovation
BOA Biomedical seeks to address antibiotic resistance and sepsis
Harvard’s Wyss Institute and VC firm Miraki Innovation have created a joint venture BOA Biomedical, which is developing a device that could diagnose and treat infectious diseases.
Promoted
The supply chain crisis is spurring companies to transform production and sourcing strategies to reduce risk
The report, Resilience in volatility: Modernizing the supply chain, highlights three areas that Fortune 500 and mid-size companies need to address to implement technology such as machine learning, cloud computing and risk management tools to improve production and delivery.
Promoted
Medical-Commercial Collaborating to Win in the Digital Era
It’s clear that life science companies need to transform their approach to be much more collaborative in the way they work with healthcare professionals.
